Application of 25-hydroxyvitamin D in treatment of intracranial benign brain tumor
A technology for hydroxyvitamin and brain tumor is applied in the application field of 25 hydroxyvitamin D in the treatment of intracranial benign brain tumor, which can solve the problem that the effect of 25 hydroxyvitamin D is not very clear.
Inactive Publication Date: 2015-11-11
SHENGJING HOSPITAL OF CHINA MEDICAL UNIV
View PDF2 Cites 0 Cited by
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
However, the role of 25-hydroxyvitamin D in benign intracranial tumors, especially meningiomas and pituitary tumors, is not very clear.
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View moreImage
Smart Image Click on the blue labels to locate them in the text.
Smart ImageViewing Examples
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0025] Meningioma patients took vitamin D1000IU orally every day for a total of 30 days.
Embodiment 2
[0027] Patients with pituitary tumors took vitamin D1000IU orally every day for a total of 30 days.
Embodiment 3
[0029] Meningioma patients took vitamin D800IU orally every day for a total of 60 days.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more PUM
Login to view more Abstract
The invention relates to an application of 25-hydroxyvitamin D in treatment of an intracranial benign brain tumor. Through application of the 25-hydroxyvitamin D in treatment of the intracranial benign brain tumor, the 25-hydroxyvitamin D in serum is promoted to 25ng / l from 10ng / l, and the hypophysis tumor volume is reduced by MRI (Magnetic Resonance Image) reexamination.
Description
technical field [0001] The invention provides a drug application, in particular relates to an application of 25-hydroxyvitamin D in the treatment of benign intracranial brain tumors, and is especially suitable for application in meningiomas and pituitary tumors. Background technique [0002] Meningioma and pituitary tumor are common benign tumors in neurosurgery. Usually divided into invasive and non-invasive. Invasive meningiomas and pituitary tumors are one of the most vexing problems in the management of benign neurosurgical tumors due to their aggressive growth properties. What causes the aggressiveness and rapid growth of these tumors is currently unclear. [0003] 25-Hydroxyvitamin D is both a vitamin and a hormone. It inhibits cell growth, promotes differentiation, anti-infection, anti-inflammatory and immunomodulatory effects. However, the role of 25-hydroxyvitamin D in benign intracranial tumors, especially meningioma and pituitary tumor, is not very clear. Co...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more Application Information
Patent Timeline
Login to view more IPC IPC(8): A61K31/59A61P35/00
Inventor 张雷刘云会
Owner SHENGJING HOSPITAL OF CHINA MEDICAL UNIV
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Try Eureka
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap